Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

CEO Of Black AIDS Institute Discusses HIV/AIDS At Newspaper Conference; Group Releases Report Examining HIV Testing In Black Community
Phill Wilson, CEO of the Black AIDS Institute (BAI), last week addressed the annual convention of the National Newspapers Publishers Association where he discussed the reasons blacks "were so slow to grasp the severity of the threat" of HIV, the NNPA/Seattle Medium reports. According to Wilson, many blacks believed that HIV/AIDS was not directly affecting their communities in the early years of the epidemic. In addition, he said when AIDS reached its peak between 1980 and 1982, blacks also were dealing with unemployment, poverty and welfare reform and, as a result, addressing HIV/AIDS was not a priority. Wilson also noted the reluctance by blacks to deal with the stigma related to the virus. Wilson said, however, "I"m more optimistic now around mobilizing black folks around HIV than [ever] before. I think we"ve made tremendous stride[s] and our institutions across the board are at a different place than they were" (Curry, 7/1).
generic viagra online
New Report Finds American Obesity Rates Climb Again - Fruits & Vegetables Important To Combating Obesity
Adult obesity rates did not decrease in a single state over the past year, but rather increased in 23 states. Also, the percentage of obese and overweight children is now at or above 30 percent in 30 states.
News of the day
Risky Skin-Care Habits Increasing Among Asian-Americans
A new survey from the Stanford University School of Medicine suggests that a significant number of Asian Americans living in California adopt unhealthy sun-exposure behaviors as they become more westernized. The findings underscore a need for increased skin-health awareness on the part of primary care physicians, dermatologists and people of Asian ancestry, who may incorrectly assume that pigmented skin and hair protect against skin cancer.
Public Health

Prospect Therapeutics, Inc.'s GCS-100 Inhibited Blood Vessel Formation In A Variety Of Cancer Models

Joseph F. Finn, Jr., C.P.A. ("Finn"), announced today that there has been promising initial interest from pharma companies in the intellectual property of Prospect Therapeutics, Inc. ("Prospect"). In preclinical studies, GCS-100 inhibited blood vessel formation in a variety of cancer models. Development and growth of solid tumors requires new blood vessel growth, or angiogenesis, to deliver oxygen and nutrients to a tumor. Galectin-3 also plays an important role in stimulating angiogenesis in a variety of tissues. The intellectual property, regulatory dossier, fixed assets and clinical inventory will be sold at auction on Monday, June 29, 2009 at 12:00 noon. Persons interested in bidding must sign a Confidentiality Agreement ("CA") obtained from Finn"s Office - jffinnjr@earthlink.net or 781-237-8840. They will then receive a bid package. About Prospect Therapeutics, Inc. Prospect"s lead product candidate, GCS-100, is a carbohydrate molecule designed to inhibit the activity of Galectin-3, a protein found in high concentration in a broad range of human cancers and whose over-expression is associated with poor prognosis in cancer patients. Joseph F. Finn, Jr., C.P.A.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009